En español
NIDA

Methamphetamine

NIDA Avant-Garde-Medications Development Award winners announced

Scientists proposing to develop vaccines against methamphetamine and nicotine have been selected to receive NIDA's second Avant-Garde Awards for Innovative Medication Development Research. The two scientists, Dr. Thomas Kosten, of Baylor College of Medicine, Houston, and Dr.


Letter from the Director

The abuse of methamphetamine—a potent and highly addictive stimulant—remains an extremely serious problem in the United States. According to data from the 2012 National Survey on Drug Use and Health (NSDUH), over 12 million people (4.7 percent of the population) have tried methamphetamine at least once. NSDUH also reports that approximately 1.2 million people used methamphetamine in the year leading up to the survey.

Two Problem-Based Learning Cases: Methamphetamine

Summary

Presents two problem-based learning case studies that introduce students to clinical presentations of substance abuse problems, particularly methamphetamine abuse.

Resource Materials

Details

Methamphetamine Lecture and Interclerkship

Summary

Examines methamphetamine abuse and dependence in the United States. Discusses diagnosis, mechanism of action, and treatment options.

Resource Materials

Details

Medication Reduces Rats' Return to Methamphetamine Seeking

Reports on a new medication strategy under investigated in animal studies that shows promise for preventing relapse to drug abuse.

Methamphetamine Abuse Undermines Dental Health

Describes research that sheds light on the correlation between increased dental disease and methamphetamine abuse.

Sertraline Does Not Help Methamphetamine Abusers Quit

Describes a new research finding indicating that the antidepressant sertraline (Zoloft), prescribed to relieve depression during the methamphetamine withdrawal process, may make quitting harder.

Bupropion Reduces Meth's Subjective Effects and Cue-Induced Craving

Describes a study investigating the use of the antidepressant bupropion as a potential therapy for methamphetamine addiction.

Methamphetamine Restricts Fetal Growth, Increases Lethargy in Newborns

Reports on research showing that newborns whose mothers abused methamphetamine during pregnancy showed lower rates of fetal growth as compared with unexposed newborns.

Pages